The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 4,020 | 499,996 | SH | SOLE | 499,996 | 0 | 0 | ||
ADC THERAPEUTICS SA | SHS | H0036K147 | 145 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 2,554 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 7,466 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 8,820 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 170,959 | 2,503,059 | SH | SOLE | 2,503,059 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 69,803 | 2,668,316 | SH | SOLE | 2,668,316 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 8,622 | 83,500 | SH | SOLE | 83,500 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 6,199 | 379,629 | SH | SOLE | 379,629 | 0 | 0 | ||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 1,523 | 11,300 | SH | SOLE | 11,300 | 0 | 0 | ||
BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 465 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 9,281 | 933,743 | SH | SOLE | 933,743 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 21,403 | 761,398 | SH | SOLE | 761,398 | 0 | 0 | ||
CENTURY THERAPEUTICS INC | COM | 15673T100 | 2,218 | 224,300 | SH | SOLE | 224,300 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 50,166 | 2,551,703 | SH | SOLE | 2,551,703 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | 581 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
DEXCOM INC | COM | 252131107 | 3,222 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
FATE THERAPEUTICS INC | COM | 31189P102 | 7,420 | 331,096 | SH | SOLE | 331,096 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 24,504 | 2,045,442 | SH | SOLE | 2,045,442 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 10,785 | 243,500 | SH | SOLE | 243,500 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 38,650 | 624,500 | SH | SOLE | 624,500 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 3,231 | 579,061 | SH | SOLE | 579,061 | 0 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 10,281 | 220,953 | SH | SOLE | 220,953 | 0 | 0 | ||
JOUNCE THERAPEUTICS INC | COM | 481116101 | 3,276 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 7,760 | 34,500 | SH | SOLE | 34,500 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | SPON ADS | 589492107 | 861 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 15,435 | 221,000 | SH | SOLE | 221,000 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 2,101 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NUVALENT INC | COM | 670703107 | 3,888 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 19,306 | 243,400 | SH | SOLE | 243,400 | 0 | 0 | ||
STOKE THERAPEUTICS INC | COM | 86150R107 | 9,803 | 763,456 | SH | SOLE | 763,456 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 22,725 | 474,929 | SH | SOLE | 474,929 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | 11,364 | 533,264 | SH | SOLE | 533,264 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 13,540 | 1,324,868 | SH | SOLE | 1,324,868 | 0 | 0 | ||
XILIO THERAPEUTICS INC | COM | 98422T100 | 7,057 | 2,425,000 | SH | SOLE | 2,425,000 | 0 | 0 |